p(1),p(5)-di(adenosine-5'-)pentaphosphate has been researched along with nicardipine in 1 studies
Studies (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Trials (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Recent Studies (post-2010) (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Studies (nicardipine) | Trials (nicardipine) | Recent Studies (post-2010) (nicardipine) |
---|---|---|---|---|---|
215 | 2 | 26 | 2,646 | 444 | 312 |
Protein | Taxonomy | p(1),p(5)-di(adenosine-5'-)pentaphosphate (IC50) | nicardipine (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 8.314 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 8 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 4.2992 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.42 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 1.69 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2.5 | |
Cytochrome P450 2J2 | Homo sapiens (human) | 1.69 | |
Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 4.925 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 4.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bustamante, C; de Terreros, FJ; Díaz-Hernández, M; Gualix, J; Miras-Portugal, MT; Pintor, J | 1 |
1 other study(ies) available for p(1),p(5)-di(adenosine-5'-)pentaphosphate and nicardipine
Article | Year |
---|---|
Presence of dinucleotide and ATP receptors in human cerebrocortical synaptic terminals.
Topics: Adenosine Triphosphate; Animals; Binding, Competitive; Calcium; Calcium Channel Blockers; Cerebral Cortex; Dinucleoside Phosphates; Humans; In Vitro Techniques; Inosine Nucleotides; Membrane Potentials; Nicardipine; Nickel; Presynaptic Terminals; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rabbits; Receptors, Purinergic P1; Receptors, Purinergic P2; Synaptosomes; Vasoconstrictor Agents; Venoms | 1999 |